[
  {
    "ts": null,
    "headline": "2 Reasons Regeneron Stock Could Crush the Market for the Next 10 Years",
    "summary": "The pharmaceutical specialist has had strong momentum over the past six months, and that could continue for a while.",
    "url": "https://finnhub.io/api/news?id=27110e79caeb80151610cdc74fc9d90cf78028535361cc94180fd995aecff20e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771979760,
      "headline": "2 Reasons Regeneron Stock Could Crush the Market for the Next 10 Years",
      "id": 139203163,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The pharmaceutical specialist has had strong momentum over the past six months, and that could continue for a while.",
      "url": "https://finnhub.io/api/news?id=27110e79caeb80151610cdc74fc9d90cf78028535361cc94180fd995aecff20e"
    }
  },
  {
    "ts": null,
    "headline": "Assessing Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Cooling",
    "summary": "Why Regeneron Pharmaceuticals stock is on investor radar today Regeneron Pharmaceuticals (REGN) is drawing attention after a period in which its share price has moved between negative weekly returns and a modest gain over the past month. This recent performance is prompting investors to reassess its current valuation and fundamentals. See our latest analysis for Regeneron Pharmaceuticals. At around US$772 per share, Regeneron’s recent 1 day and 7 day share price declines sit against a mildly...",
    "url": "https://finnhub.io/api/news?id=14653877e51ec50ade20ff440e093e0352aa73197ffaebe959ae3353e7cdcf65",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771979048,
      "headline": "Assessing Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Cooling",
      "id": 139203164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Why Regeneron Pharmaceuticals stock is on investor radar today Regeneron Pharmaceuticals (REGN) is drawing attention after a period in which its share price has moved between negative weekly returns and a modest gain over the past month. This recent performance is prompting investors to reassess its current valuation and fundamentals. See our latest analysis for Regeneron Pharmaceuticals. At around US$772 per share, Regeneron’s recent 1 day and 7 day share price declines sit against a mildly...",
      "url": "https://finnhub.io/api/news?id=14653877e51ec50ade20ff440e093e0352aa73197ffaebe959ae3353e7cdcf65"
    }
  }
]